drugset / Trial / NCT00521456

A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery

NCT00521456

Phase 3 Completed 263 enrolled Allergan
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a 16 day study to evaluate the safety and efficacy of ketorolac eye drops for the treatment of inflammation and pain associated with cataract surgery

Timeline

Start
2007-10
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified 0.45 % Topical

Indications